Cargando…
Challenges of defining renal response in ANCA-associated vasculitis: call to action?
Avoiding end-stage kidney disease in patients with anti-neutrophil cytoplasmic antibody–associated vasculitis (AAV) has a high therapeutic priority. Although renal response is a crucial measure to capture clinically relevant changes, clinal trials have used various definitions and no well-studied ke...
Autores principales: | Odler, Balazs, Bruchfeld, Annette, Scott, Jennifer, Geetha, Duvuru, Little, Mark A, Jayne, David R W, Kronbichler, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229283/ https://www.ncbi.nlm.nih.gov/pubmed/37261001 http://dx.doi.org/10.1093/ckj/sfad009 |
Ejemplares similares
-
Risk factors for serious infections in ANCA-associated vasculitis
por: Odler, Balazs, et al.
Publicado: (2023) -
The COVID-19 pandemic and ANCA-associated vasculitis – reports from the EUVAS meeting and EUVAS education forum
por: Kronbichler, Andreas, et al.
Publicado: (2021) -
COVID-19 and ANCA-associated vasculitis: recommendations for vaccine preparedness and the use of rituximab
por: Bruchfeld, Annette, et al.
Publicado: (2021) -
Immune checkpoint inhibitors as potential triggers for ANCA vasculitis
por: Aqeel, Faten, et al.
Publicado: (2022) -
Older patients with ANCA-associated vasculitis and dialysis dependent renal failure: a retrospective study
por: Manno, Rebecca L., et al.
Publicado: (2015)